QuidelOrtho (QDEL) Q2 FY26 earnings call

QuidelOrtho reported mixed Q2 FY26 results, demonstrating strong underlying performance in its core businesses and geographies outside of China, which drove 6% revenue growth and significant EBITDA margin expansion. However, persistent headwinds in China due to IVD pricing uncertainty and a more cautious outlook for the respiratory season led to a downward revision of full-year financial guidance and the withdrawal of free cash flow guidance. Management is intensely focused on improving cash conversion and reducing leverage.